Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

New rapid-release gas treatment for ambulances could remove Covid-19 contamination

Researchers from the university are helping slash the time it takes to clean an ambulance from 45 minutes to under 20 minutes.

30 Apr 2020

Re-establishing pharmaceutical chemical production in Europe in the wake of COVID-19

Over 80% of chemicals used to make pharmaceuticals sold in Europe originate from China or India, according to the European Fine Chemicals Group.

30 Apr 2020

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.

30 Apr 2020

Remdesivir shows powerful activity against SARS-CoV-2 in Vitro

Remdesivir is an antiviral first developed by Gilead in 2014 as a treatment for Ebola and Marburg viruses. However, scientists explored its possibilities as a broad-spectrum drug when it proved effective against SARS-CoV and MERS-CoV, coronaviruses which were responsible for earlier outbreaks.

30 Apr 2020

Online searches for unproven therapies for COVID-19

A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.

29 Apr 2020

Antibody produced by llamas shows promise against SARS-CoV-2

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter.

29 Apr 2020

New clinical trial launched to study if convalescent plasma can treat COVID-19

Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma- taken from people who have recovered from COVID-19-;is effective in treating the disease.

29 Apr 2020

CZI commits $13.6 million for large-scale research collaboration on COVID-19

Today, the Chan Zuckerberg Initiative committed $13.6 million to stand up a large-scale research collaboration between UC San Francisco, Stanford University, and the Chan Zuckerberg Biohub that aims to better understand the spread of COVID-19 across the San Francisco Bay Area.

29 Apr 2020

Study: 14.4 million U.S. workers face exposure to infection on the job

A University of Washington researcher calculates that 14.4 million workers face exposure to infection once a week and 26.7 million at least once a month in the workplace, pointing to an important population needing protection as the novel coronavirus disease, COVID-19, continues to break out across the U.S.

29 Apr 2020

Food crisis and socioeconomic impacts of COVID-19 in the hungriest countries

The number of people battling acute hunger and suffering from malnutrition is on the rise again. The upheaval set in motion by the COVID-19 pandemic may push even more families and communities into deeper distress.

29 Apr 2020

Further evidence 'pooling of samples' for SARS-CoV-2 helps boost testing capacity

One of the problems faced by health officials today is the vast number of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as they can still transmit the virus. Therefore the testing of as many people as possible is crucial for immediate isolation of cases to prevent the virus from spreading further.

29 Apr 2020

Arthritis drug assessed as potential treatment for COVID-19-related pneumonia

UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have therapeutic value for COVID-19 patients who have developed or at high risk of developing serious lung damage from SARS-CoV-2 infections.

29 Apr 2020

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Researchers at the Radboud University Medical Center seem to have found an essential mechanism in the disease process of COVID-19, which has so far been overlooked.

29 Apr 2020

New study could improve our understanding about platelets

University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.

29 Apr 2020

Trump says N95 masks can be sterilized for reuse. Only in a pinch, experts warn.

As COVID-19 cases continue to climb, front-line health care workers are decrying unsafe working conditions — in particular, describing inadequate access to personal protective equipment, or PPE.

29 Apr 2020

Australian COVID-19 vaccine candidate shows protective response in pre-clinical trials

Amid the coronavirus pandemic, scientists race to develop a vaccine that can help contain the spread of the virus. The coronavirus disease (COVID-19) has so far infected more than 3.18 million people across the globe. Now, early tests of a potential coronavirus vaccine have shown promise in pre-clinical trials.

29 Apr 2020

Coronaviruses represent a source of pandemic viruses

In a new paper published on the preprint journal bioRxiv in April 2020, researcher T. Konishi argues that the coronavirus family is a constellation of pandemic pathogens, that includes the currently spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Apr 2020

What is the incubation period of COVID-19?

Despite the fact that the COVID-19 pandemic has been raging for over four months the world over, the incubation period has not been reliably estimated. A new study published on the preprint server medRxiv reviews the various attempts made so far to arrive at a more accurate estimate.

29 Apr 2020

Low levels of vitamin D may be linked to severe COVID-19

A new observational study from the United States indicates that vitamin D insufficiency may play a significant role in the progression of coronavirus disease (COVID-19). The research titled 'Vitamin D Insufficiency is Prevalent in Severe COVID-19' is available on the preprint server medRxiv.Study shows that low levels of vitamin D may be linked to severe COVID-19

29 Apr 2020

ACE inhibitors appear to be safe and beneficial for COVID-19, say researchers

Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among patients with COVID-19.

29 Apr 2020